Dissociation of janus kinase 2 and signal transducer and activator of transcription 5 activation after treatment of nb2 cells with a molecular mimic of phosphorylated prolactin

被引:26
作者
Coss, D
Kuo, CB
Yang, L
Ingleton, P
Luben, R
Walker, AM [1 ]
机构
[1] Univ Calif Riverside, Div Biomed Sci, Riverside, CA 92521 USA
[2] Univ Sheffield, Sch Med, Div Biochem & Musculoskeletal Med, Sheffield S10 2RX, S Yorkshire, England
关键词
D O I
10.1210/en.140.11.5087
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We have previously demonstrated that phosphorylated PRL acts as an antagonist to the Nb2 proliferative activities of unmodified PRL. A molecular mimic of phosphorylated PRL, which substitutes an aspartate residue for the normally phosphorylated serine (serine 179), has the same properties. Because it takes less than one fourth the amount of phosphorylated hormone, or the aspartate mutant, to block the proliferative activity of unmodified hormone, we have investigated whether the high potency of the aspartate mutant is achieved by the production of an alternate and interfering intracellular signal cascade. Nb2 cells were exposed to 5 or 500 ng/ml human NIDDK PRL, wild-type recombinant PRL (unmodified PRL), or aspartate mutant PRL (pseudophosphorylated PRL) for 1, 5, or 10 min at 37 C. At 5 ng/ml and 10 min, wild-type recombinant PRL showed greater activation of Janus kinase 2 (JAK 2) than the NIDDK preparation. This is consistent with a previous report of higher proliferative activity for the wild-type hormone and is primarily a reflection of the presence of some phosphorylated hormone in the NIDDK preparation. At 500 ng/ml and 10 min, saturation eliminated any differences between responses to the two preparations. JAK 2 activation was not seen in response to the aspartate mutant at either concentration. Signal transducer and activator of transcription 5 (STAT 5) activation was, however,just as robust for the aspartate-treated cells as for the other two groups. Time course experiments eliminated the possibility that STAT 5 phosphorylation in response to the aspartate mutant was the result of JAK 2 activation at earlier time points. Experiments in the present study also interestingly showed preassociation of JAK 2 and STAT 5 in the absence of PRL and the absence of detectable phosphorylation of either JAK 2 or STAT 5. Like JAK 2, receptor phosphorylation was absent with the aspartate mutant. A comparison between STAT 5a and STAT 5b activation showed a marked reduction in STAT 5b phosphorylation in response to the aspartate mutant, with concomitant reduction in STAT 5a-STAT 5b heterodimers. STAT 5a activation, however, was indistinguishable between the wild-type and aspartate mutant. We conclude that the nonproliferative aspartate mutant signals and activates STAT 5 without, or with minimal, use of JAK 2 or receptor phosphorylation. The wild-type proliferative PRL, on the other hand, uses receptor phosphorylation and JAK 2 activation.
引用
收藏
页码:5087 / 5094
页数:8
相关论文
共 44 条
[1]   Prolactin receptor regulates Stat5 tyrosine phosphorylation and nuclear translocation by two separate pathways [J].
Ali, S ;
Ali, S .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (13) :7709-7716
[2]   PROLACTIN RECEPTOR IS ASSOCIATED WITH C-SRC KINASE IN RAT-LIVER [J].
BERLANGA, JJ ;
VARA, JAF ;
MARTINPEREZ, J ;
GARCIARUIZ, JP .
MOLECULAR ENDOCRINOLOGY, 1995, 9 (11) :1461-1467
[3]   Prolactin (PRL) and its receptor: Actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice [J].
Bole-Feysot, C ;
Goffin, V ;
Edery, M ;
Binart, N ;
Kelly, PA .
ENDOCRINE REVIEWS, 1998, 19 (03) :225-268
[4]   ACTIVATION OF JAK2 TYROSINE KINASE BY PROLACTIN RECEPTORS IN NB-2 CELLS AND MOUSE MAMMARY-GLAND EXPLANTS [J].
CAMPBELL, GS ;
ARGETSINGER, LS ;
IHLE, JN ;
KELLY, PA ;
RILLEMA, JA ;
CARTERSU, C .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (12) :5232-5236
[5]   Characterization of Stat5a and Stat5b homodimers and heterodimers and their association with the glucocortiocoid receptor in mammary cells [J].
Cella, N ;
Groner, B ;
Hynes, NE .
MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (04) :1783-1792
[6]   Development of recombinant human prolactin receptor antagonists by molecular mimicry of the phosphorylated hormone [J].
Chen, TJ ;
Kuo, CB ;
Tsai, KF ;
Liu, JW ;
Chen, DY ;
Walker, AM .
ENDOCRINOLOGY, 1998, 139 (02) :609-616
[7]   THE PROTEIN-TYROSINE KINASE P59(FYN) IS ASSOCIATED WITH PROLACTIN (PRL) RECEPTOR AND IS ACTIVATED BY PRL STIMULATION OF T-LYMPHOCYTES [J].
CLEVENGER, CV ;
MEDAGLIA, MV .
MOLECULAR ENDOCRINOLOGY, 1994, 8 (06) :674-681
[8]   THE HEMATOPOIETIN RECEPTOR SUPERFAMILY [J].
COSMAN, D .
CYTOKINE, 1993, 5 (02) :95-106
[9]   STATs and gene regulation [J].
Darnell, JE .
SCIENCE, 1997, 277 (5332) :1630-1635
[10]   Prolactin recruits STAT1, STAT3 and STAT5 independent of conserved receptor tyrosines TYR402, TYR479, TYR515 and TYR580 [J].
DaSilva, L ;
Rui, H ;
Erwin, RA ;
Howard, OMZ ;
Kirken, RA ;
Malabarba, MG ;
Hackett, RH ;
Larner, AC ;
Farrar, WL .
MOLECULAR AND CELLULAR ENDOCRINOLOGY, 1996, 117 (02) :131-140